Stay updated on Metformin in Longevity Study (MILES) Clinical Trial
Sign up to get notified when there's something new on the Metformin in Longevity Study (MILES) Clinical Trial page.

Latest updates to the Metformin in Longevity Study (MILES) Clinical Trial page
- Check4 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations/New York added; revision updated to v3.3.3. HHS Vulnerability Disclosure and New York Locations removed; revision updated from v3.3.2.SummaryDifference0.2%

- Check54 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved a general operating status notice about funding lapse from the page. The study details, eligibility criteria, and contact information remain unchanged.SummaryDifference0.4%

- Check76 days agoChange DetectedAn updated last update date (2021-05-21) appears in the Study Record Dates, indicating a revision to the record. The page retains results-related entries showing ongoing updates to results information.SummaryDifference0.4%

- Check105 days agoChange DetectedSummary: The page now displays a funding-status notice and announces a major version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

Stay in the know with updates to Metformin in Longevity Study (MILES) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Metformin in Longevity Study (MILES) Clinical Trial page.